Loading...
Camurus AB (publ)
CAMRF•PNK
Healthcare
Biotechnology
$71.00
$0.00(0.00%)
Camurus AB (publ) (CAMRF) Financial Performance & Income Statement Overview
Review Camurus AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.78%
↑ 8.78%
Operating Income Growth
-11.87%
↓ 11.87%
Net Income Growth
-0.71%
↓ 0.71%
Operating Cash Flow Growth
-36.07%
↓ 36.07%
Operating Margin
30.91%
↑ 30.91%
Gross Margin
93.04%
↑ 93.04%
Net Profit Margin
26.91%
↑ 26.91%
ROE
17.10%
↑ 17.10%
ROIC
17.58%
↑ 17.58%
Camurus AB (publ) (CAMRF) Income Statement & Financial Overview
Review Camurus AB (publ)'s (CAMRF) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $558.34M | $553.13M | $479.60M | $444.87M |
Cost of Revenue | $39.29M | $33.32M | $33.51M | $35.55M |
Gross Profit | $519.05M | $519.81M | $446.08M | $409.32M |
Gross Profit Ratio | $0.93 | $0.94 | $0.93 | $0.92 |
R&D Expenses | $131.45M | $167.29M | $162.76M | $169.80M |
SG&A Expenses | $157.40M | $181.44M | $138.52M | $154.67M |
Operating Expenses | $280.17M | $353.74M | $304.26M | $324.47M |
Total Costs & Expenses | $319.46M | $387.06M | $337.77M | $360.02M |
Interest Income | $16.41M | $20.46M | $23.72M | $21.78M |
Interest Expense | $1.33M | $284000.00 | $235000.00 | $277000.00 |
Depreciation & Amortization | $5.64M | $3.51M | $3.69M | $3.75M |
EBITDA | $260.94M | $190.04M | $169.24M | $88.59M |
EBITDA Ratio | $0.47 | $0.34 | $0.35 | $0.20 |
Operating Income | $238.88M | $166.07M | $141.83M | $84.85M |
Operating Income Ratio | $0.43 | $0.30 | $0.30 | $0.19 |
Other Income/Expenses (Net) | $15.08M | $20.18M | $23.48M | $19.26M |
Income Before Tax | $253.96M | $186.24M | $165.31M | $104.11M |
Income Before Tax Ratio | $0.45 | $0.34 | $0.34 | $0.23 |
Income Tax Expense | $56.71M | $39.26M | $35.96M | $29.91M |
Net Income | $197.25M | $146.98M | $129.35M | $74.20M |
Net Income Ratio | $0.35 | $0.27 | $0.27 | $0.17 |
EPS | $3.35 | $2.50 | $2.21 | $1.28 |
Diluted EPS | $3.29 | $2.45 | $2.16 | $1.25 |
Weighted Avg Shares Outstanding | $58.88M | $58.82M | $58.65M | $57.78M |
Weighted Avg Shares Outstanding (Diluted) | $59.92M | $59.93M | $59.92M | $59.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan